Image Analysis Group
Contact Us
  • Therapeutic Expertise
  • Trial Solutions

    Trial Solutions

    • Collect&Hold
      • Budget Friendly Collect and Hold Solution
    • EarlyPhase
      • Early Phase Trials
    • LatePhase
      • Late Phase Clinical Trials
    • Other Imaging
      • RWE, AI Studies and More
  • DYNAMIKA™
  • Useful Resources

    Useful Resources

    • Text Publications
      • Industry Digest
      • DYNAMIKA Spotlight
      • Knowledge Base
      • Company News
      • IAG Partnerships
      • Events
  • About Us

    About Us

    • Image Analysis Group
      • Why Us
    • Team
      • Leadership Team
      • Expert Network
Contact Us
Latest AI in Trials AI Tech Arthritis Biotech News Clin Ops Clinical Trials Trends Company News Data & Compliance Drug Development DYNAMIKA Events IAG Partnerships Image Analysis Group Industry Digest Regulatory Updates SCOPE 2026
Oncology clinical trial imaging and protocol endpoint strategy - Image Analysis Group (IAG)
Company News March 9, 2026
Protocol and Endpoint Considerations in Oncology Trials
Centralized Imaging Review in Immuno-Oncology Trials — Reducing Variability & Improving Endpoint Reliability | IAG Image Analysis Group
Company News March 9, 2026
How Centralized Imaging Reduces Variability in Immuno-Oncology Trials
Image Analysis Group Leadership Expansion with Derek Hunter and Jonathan Shaul, serving as Head of Quality and Chief Financial Officer, standing together in a professional setting.
Company News February 23, 2026
Image Analysis Group (IAG) Expands Executive Leadership Across Quality and Finance

Phone:

UK: +44 2038 211 563
USA: +1 267 857 8638

Email:

contact@ia-grp.com

Address:

12 Hammersmith Grove, London, W6 7AE

  • Why Work with IAG?
  • Privacy Statement
  • Therapeutic Expertise
  • Cookie Policy
  • DYNAMIKA™
  • Compliance
  • Trial Solutions
  • Disclaimer
  • empty
  • Imprint

Copyright © 2026 Image Analysis Group. All Rights Reserved